Vasculitis

2019-20 coronavirus outbreak

Biopsy

Physical examination

Erythema

Surgery

Virology

Dermis

Dermatology

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Outbreak

Coronavirus disease 2019 (COVID-19)

Lesion

Immunology

Leukocytoclastic vasculitis

Papule

Henoch-Schonlein purpura

Family medicine

Infectious disease (medical specialty)

Internal medicine

Skin biopsy

Medicine

Venereology

Palpable purpura

Disease

Pathology

International Journal of Dermatology

International Journal of DermatologyVolume 60, Issue 10 p. 1305-1306 Correspondence New-onset leukocytoclastic vasculitis after COVID-19 vaccine Ecem Bostan MD, Corresponding Author Ecem Bostan MD [email protected] Department of Dermatology and Venereology, Faculty of Medicine, Hacettepe University, Ankara, TurkeySearch for more papers by this authorDuygu Gulseren MD, Duygu Gulseren MD orcid.org/0000-0003-1602-726X Department of Dermatology and Venereology, Faculty of Medicine, Hacettepe University, Ankara, TurkeySearch for more papers by this authorOzay Gokoz MD, Ozay Gokoz MD Department of Pathology, Faculty of Medicine, Hacettepe University, Ankara, TurkeySearch for more papers by this author Ecem Bostan MD, Corresponding Author Ecem Bostan MD [email protected] Department of Dermatology and Venereology, Faculty of Medicine, Hacettepe University, Ankara, TurkeySearch for more papers by this authorDuygu Gulseren MD, Duygu Gulseren MD orcid.org/0000-0003-1602-726X Department of Dermatology and Venereology, Faculty of Medicine, Hacettepe University, Ankara, TurkeySearch for more papers by this authorOzay Gokoz MD, Ozay Gokoz MD Department of Pathology, Faculty of Medicine, Hacettepe University, Ankara, TurkeySearch for more papers by this author First published: 09 July 2021 https://doi.org/10.1111/ijd.15777Citations: 47 Conflict of interest: None. Funding source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Cohen SR, Prussick L, Kahn JS, et al. Leukocytoclastic vasculitis flare following the COVID-19 vaccine. Int J Dermatol. 2021. https://doi.org/10.1111/ijd.15623. Epub ahead of print. PMID: 33928638. 10.1111/ijd.15623 Web of Science®Google Scholar 2Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183: 71–77. 10.1111/bjd.19163 CASPubMedWeb of Science®Google Scholar 3Tirumalae R. Histopathologic approach to cutaneous vasculitis. Indian J Dermatopathol Diagn Dermatol 2014; 1: 2–6. 10.4103/2349-6029.135186 Google Scholar 4Bonetto C, Trotta F, Felicetti P, et al. Vasculitis as an adverse event following immunization - Systematic literature review. Vaccine 2016; 34: 6641–6651. 10.1016/j.vaccine.2015.09.026 CASPubMedWeb of Science®Google Scholar 5Duggal T, Segal P, Shah M, et al. Antineutrophil cytoplasmic antibody vasculitis associated with influenza vaccination. Am J Nephrol 2013; 38: 174–178. 10.1159/000354084 CASPubMedWeb of Science®Google Scholar Citing Literature Volume60, Issue10October 2021Pages 1305-1306 ReferencesRelatedInformation

New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine